2017
DOI: 10.1016/j.tube.2017.07.006
|View full text |Cite
|
Sign up to set email alerts
|

Down-regulation of malate synthase in Mycobacterium tuberculosis H37Ra leads to reduced stress tolerance, persistence and survival in macrophages

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
11
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 20 publications
(11 citation statements)
references
References 38 publications
0
11
0
Order By: Relevance
“…For example, Staphylococcus aureus, a facultative intracellular pathogen, alters its central carbon metabolism to promote its survival in the phagosome (60,61). The ability to utilize short-chain fatty acids is required for full virulence of Campylobacter jejuni (62), and Mycobacterium tuberculosis requires the glyoxylate shunt for survival in macrophages and mice (63,64). Here, we show that, similarly to many other pathogens, C. albicans appropriately responds to multiple alternative carbon sources to gain advantages over the host.…”
Section: Discussionmentioning
confidence: 99%
“…For example, Staphylococcus aureus, a facultative intracellular pathogen, alters its central carbon metabolism to promote its survival in the phagosome (60,61). The ability to utilize short-chain fatty acids is required for full virulence of Campylobacter jejuni (62), and Mycobacterium tuberculosis requires the glyoxylate shunt for survival in macrophages and mice (63,64). Here, we show that, similarly to many other pathogens, C. albicans appropriately responds to multiple alternative carbon sources to gain advantages over the host.…”
Section: Discussionmentioning
confidence: 99%
“…The investigation of novel pharmacological targets, such as InhA, MmpL3, DprE1 and QcrB, plays a fundamental role in the development of new potential antitubercular agents [4]. Since the most promising targets are membrane proteins, the identified hit compounds may also interfere with the integrity of the host membranes; therefore, the selection of different targets to be tackled is still urgent [5][6][7][8]. In addition, there are a number of novel anti-TB compounds in clinical trial, and two new drugs have been recently approved: delamanid and bedaquiline.…”
Section: Introductionmentioning
confidence: 99%
“…Disruption of the TCA cycle, especially alternate catabolism through the glyoxylate shunt, has been linked to antibiotic tolerance in multiple bacterial species, including P. aeruginosa (64), S. aureus (65,66), and S. epidermis (67), suggesting that this pathway may be a common mechanism for promoting antibiotic tolerance. In M. tuberculosis , downregulation of the malate synthase GlcB, one of the enzymes in the glyoxylate shunt, caused increased susceptibility to both rifampin and to nitrosative and oxidative stresses in vitro (68). Deficiency of isocitrate lyase, another glyoxylate shunt enzyme, also led to increased susceptibility of M. tuberculosis to antibiotics in vitro (69) and decreased survival in activated macrophages and mice (27).…”
Section: Discussionmentioning
confidence: 99%